P16/Ki67双染、HPV以及两者联合检测对宫颈疾病的诊断价值
摘要
关键词
全文:
PDF参考
[1]于静,朱慧庭,赵晶晶,等.P16NK4a/Ki67双免疫细胞化学染色对宫颈细胞学不能明确意义的不典型鳞状细胞和低级别鳞状上皮内瘤变患者的分流作用[J].中华病理学杂志,2017,46(5):323-326.
[2]SINGH D,VIGNAT J,LORENZONI V,et al.Global estimates of incidence and mortality of cervical cancer in 2020:a baseline analysis of the WHO global cervical cancer elimination initiative[J].LancetGlob Health,2023,11(2):e197-e206.
[3]任文辉,赵雪莲,赵方辉.全球宫颈癌筛查指南制定现状的系统综述[J].中华医学杂志,2021,101(24): 1882-1889.
[4]FONTHAMETH.WOLF AMD.CHURCH TR,et al.Cervical cancer screening for individuals at average risk,2020 guideline update from the American Cancer SocietyLJI.CA Cancer[J]Clin,2020,70(5),321-346.
[5]ARBYN M,WEIDERPASS E,BRUNI L,et al.Estimates of incidence and mortality of cervical cancer in 2018:a worldwide analysis[J].Lancet Glob Health,2020.8(2).e191-e203.
[6]余桂媛,陈敏杰,闵庆华,等.871例人乳头瘤病毒16/18阳性者阴道镜活检结果的回顾性分析[J].中国当代医药,2020.27(32):8-11.
[7]CLARKE M A,CHEUNG L C,CASTLE P E,et al.Five-year risk of cervical precancer following P16/Ki67 dual-stain triage of HPV-positive women[J].JAMA Oncol,2019,5(2):181-186.
[8]郭艳利,游珂,张睿怡,等.宫颈细胞学联合高危型HPV检测在子宫颈癌及癌前病变检出中的作用[J].中国妇产科临床杂志,2017,18(1):3-6.
[9]Zhang R,Ge X,You K,et al.P16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions[J].J Obstet Gynaecol Res,2018,44(11):2077-2084.
[10]崔焱,张瑜英,潘琳.宫颈疾病患者P16/Ki67表达状况及其与HPV感染的相关性[J].川北医学院学报,2022,37(4):494-496,500.
[11]王璐杨,P16/Ki67双染检测在宫颈癌筛查分流中的应用价值[D].郑州:郑州大学,2020.
[12]舒美琴,于小红.P16/Ki67双染法诊断宫颈病变的价值[J].中国妇幼保健,2021,36(5):1165-1168.
[13]贾漫漫,赵冬梅,郭珍,等.P16/Ki67双染监测在高危型人乳头瘤病毒阳性人群中的分流效果评价[J].中华预防医学杂志,2020,54(2):192-197.
[14]吴艳,王瑾,解浩然,等.高危型HPV分型、TCT、P16/Ki67双染在宫颈癌筛查中的价值[J].中国计划生育学杂志,2022,30(12):2875-2879.
[15]Liu G,Sharma M,Tan N,et al.HIV-positive women have higher risk of human papilloma virus infection,precancerous lesions,and cervical cancer[J].AIDS,2018,32(6):795-808.
[16]郭珍,赵冬梅,贾漫漫,等.P16/Ki67蛋白双染在未明确意义的非典型鳞状上皮细胞人群中分流作用[J].中国肿瘤,2021,30(8):635-640.
Refbacks
- 当前没有refback。
